Cartesian Therapeutics, Inc. — Director's Dealing 2019

Oct 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-10-07

Reporting Person: Kishimoto Takashi Kei (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-07	Employee Stock Option (right to buy)	$1.75	A	180000	Acquired	2029-10-06	Common Stock (180000.0)	Direct

Footnotes

F1: This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021.